Scopus BioPharma Ownership | Who Owns Scopus BioPharma?
Scopus BioPharma Ownership Summary
Scopus BioPharma is owned by 0.36% institutional investors, and 99.64% retail investors.
SCPS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Scopus BioPharma | 0.36% | - | 99.64% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2022 | 1 | -91.67% | 76,819 | -83.47% | - | 7.50% | - | -100.00% | - | -100.00% |
Sep 30, 2022 | 12 | -7.69% | 464,786 | -32.10% | 2 | 20.93% | 2 | -60.00% | 4 | 100.00% |
Jun 30, 2022 | 13 | -23.53% | 684,494 | -32.12% | 3 | 14.20% | 5 | -50.00% | 2 | - |
Mar 31, 2022 | 17 | -15.00% | 1,008,382 | -65.00% | 4 | 1.71% | 10 | -16.67% | 2 | -50.00% |
Dec 31, 2021 | 20 | 81.82% | 2,881,095 | 948.47% | 16 | 650.36% | 12 | 50.00% | 4 | 33.33% |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 27, 2021 | Greenspan Ira Scott | Executive Committee Chairman | Buy | $3.93K |
Aug 27, 2021 | Greenspan Ira Scott | Executive Committee Chairman | Buy | $541.20 |
Aug 27, 2021 | Lamstein Joshua R | Chairman | Buy | $1.00K |
Aug 26, 2021 | Lamstein Joshua R | Chairman | Buy | $980.00 |
Aug 24, 2021 | Greenspan Ira Scott | Executive Committee Chairman | Buy | $232.50 |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2021 Q4 | - | - |
2021 Q3 | 16 | - |
2021 Q2 | - | - |
2021 Q1 | 15 | - |
2020 Q4 | - | - |
SCPS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools